This Article Full Text (HTML) Reprint (PDF) Submit a response to this article Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Services E-mail this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to My Personal Archive Download to Citation Manager Reprints & Permissions Citing Articles Citing Articles via HighWire Citing Articles via ISI Web of Science (6) Citing Articles via Google Scholar Google Scholar Articles by Galvin, R. S. Search for Related Content PubMed PubMed Citation Articles by Galvin, R. S. Related Collections Business Of Health Quality Of Care

Medicine & Chronic Illness

PERSPECTIVE

The Business Case For Quality

Working markets naturally reward quality. In health care, mostly because of price-insensitivity and imperfect information, rewarding quality is more frequently unnatural. Molly Joel Coye makes the compelling argument that the absence of rewards for quality has slowed its adoption as an operating strategy. Her focus is just right: Those who directly treat the chronically ill and create the most value should get the most reward. But there is reason to be cautious. New ideas in health care have a tendency to oversimplify and overpromise. Whether it be managed care, continuous quality improvement, or defined contribution, proponents seem to subscribe to . . . [Full Text of this Article]

Business case for whom?What do we mean by rewards?Who is going to pay?Next steps.

                      What's this?

This article has been cited by other articles:

				M. M. Mello, C. N. Kelly, and T. A. Brennan Fostering Rational Regulation of Patient Safety Journal of Health Politics Policy and Law, June 1, 2005; 30(3): 375 - 426. [Abstract] [PDF]

				R. Galvin and A. Milstein Large Employers' New Strategies in Health Care N. Engl. J. Med., September 19, 2002; 347(12): 939 - 942. [Full Text] [PDF]